Organigram Holdings Stock Buy Hold or Sell Recommendation
OGI Stock | USD 1.93 0.02 1.03% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding OrganiGram Holdings is 'Strong Sell'. Macroaxis provides OrganiGram Holdings buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OGI positions. The advice algorithm takes into account all of OrganiGram Holdings' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting OrganiGram Holdings' buy or sell advice are summarized below:
Real Value 3.6 | Target Price 8.8 | Hype Value 1.94 | Market Value 1.93 | Naive Value 2.02 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell OrganiGram Holdings given historical horizon and risk tolerance towards OrganiGram Holdings. When Macroaxis issues a 'buy' or 'sell' recommendation for OrganiGram Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
OrganiGram |
Execute OrganiGram Holdings Buy or Sell Advice
The OrganiGram recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on OrganiGram Holdings. Macroaxis does not own or have any residual interests in OrganiGram Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute OrganiGram Holdings' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Modest | Details | |
Volatility | Very risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
OrganiGram Holdings Trading Alerts and Improvement Suggestions
OrganiGram Holdings had very high historical volatility over the last 90 days | |
OrganiGram Holdings may become a speculative penny stock | |
The company reported the last year's revenue of 149.21 M. Reported Net Loss for the year was (229.48 M) with profit before taxes, overhead, and interest of 35.07 M. | |
OrganiGram Holdings has about 127.36 M in cash with (35.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
OrganiGram Holdings has a frail financial position based on the latest SEC disclosures | |
Roughly 27.0% of the company outstanding shares are owned by corporate insiders | |
Latest headline from news.google.com: Closing Bell Organigram Holdings Inc down on Wednesday - The Globe and Mail |
OrganiGram Holdings Returns Distribution Density
The distribution of OrganiGram Holdings' historical returns is an attempt to chart the uncertainty of OrganiGram Holdings' future price movements. The chart of the probability distribution of OrganiGram Holdings daily returns describes the distribution of returns around its average expected value. We use OrganiGram Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of OrganiGram Holdings returns is essential to provide solid investment advice for OrganiGram Holdings.
Mean Return | 0.25 | Value At Risk | -8.3 | Potential Upside | 10.24 | Standard Deviation | 6.02 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of OrganiGram Holdings historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
OrganiGram Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as OrganiGram Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading OrganiGram Holdings backward and forwards among themselves. OrganiGram Holdings' institutional investor refers to the entity that pools money to purchase OrganiGram Holdings' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Susquehanna International Group, Llp | 2023-12-31 | 102.6 K | Two Sigma Investments Llc | 2023-12-31 | 84 K | Goldman Sachs Group Inc | 2023-12-31 | 65.4 K | Two Sigma Advisers, Llc | 2023-12-31 | 57.1 K | Vontobel Holding Ltd. | 2023-12-31 | 54.3 K | Bank Of America Corp | 2023-12-31 | 45.3 K | Group One Trading, Lp | 2023-12-31 | 42 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 40.8 K | Canton Hathaway, Llc | 2023-12-31 | 37.8 K | Mirae Asset Global Investments (korea) Co Ltd | 2023-12-31 | 1.2 M | Renaissance Technologies Corp | 2023-12-31 | 522 K |
OrganiGram Holdings Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (23.0M) | 30.8M | 13.2M | (34.7M) | (31.2M) | (29.6M) | |
Free Cash Flow | (123.8M) | (40.9M) | (85.0M) | (65.6M) | (59.1M) | (62.0M) | |
Capital Expenditures | 78.7M | 12.3M | 48.8M | 30.4M | 35.0M | 35.1M | |
Net Income | (136.2M) | (130.7M) | (14.3M) | (229.5M) | (206.5M) | (196.2M) | |
End Period Cash Flow | 24.6M | 55.4M | 68.5M | 33.9M | 38.9M | 27.4M | |
Change To Inventory | (40.9M) | 45.6M | 28.7M | (12.2M) | (14.1M) | (13.3M) | |
Depreciation | 18.0M | 31.0M | 24.9M | 24.2M | 27.8M | 29.2M | |
Other Non Cash Items | 46.7M | 776K | (29.0M) | 174.0M | 200.1M | 210.1M | |
Investments | (138.2M) | (72.5M) | 95.5M | 20.1M | 23.2M | 24.3M | |
Net Borrowings | 64.0M | (116.4M) | (1.0M) | (772.6K) | (695.4K) | (660.6K) | |
Change To Netincome | 44.0M | 46.1M | (24.0M) | 174.6M | 200.8M | 210.8M |
OrganiGram Holdings Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to OrganiGram Holdings or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that OrganiGram Holdings' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a OrganiGram stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.03 | |
β | Beta against NYSE Composite | 3.10 | |
σ | Overall volatility | 6.06 | |
Ir | Information ratio | 0.03 |
OrganiGram Holdings Volatility Alert
OrganiGram Holdings is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure OrganiGram Holdings' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact OrganiGram Holdings' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.OrganiGram Holdings Fundamentals Vs Peers
Comparing OrganiGram Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze OrganiGram Holdings' direct or indirect competition across all of the common fundamentals between OrganiGram Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as OrganiGram Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of OrganiGram Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing OrganiGram Holdings by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare OrganiGram Holdings to competition |
Fundamentals | OrganiGram Holdings | Peer Average |
Return On Equity | -0.55 | -0.31 |
Return On Asset | -0.0556 | -0.14 |
Profit Margin | (1.54) % | (1.27) % |
Operating Margin | (0.44) % | (5.51) % |
Current Valuation | 146.18 M | 16.62 B |
Shares Outstanding | 103 M | 571.82 M |
Shares Owned By Insiders | 27.32 % | 10.09 % |
Shares Owned By Institutions | 8.80 % | 39.21 % |
Number Of Shares Shorted | 3.57 M | 4.71 M |
Price To Earning | (79.96) X | 28.72 X |
Price To Book | 1.06 X | 9.51 X |
Price To Sales | 1.35 X | 11.42 X |
Revenue | 149.21 M | 9.43 B |
Gross Profit | 35.07 M | 27.38 B |
EBITDA | (88.23 M) | 3.9 B |
Net Income | (229.48 M) | 570.98 M |
Cash And Equivalents | 127.36 M | 2.7 B |
Cash Per Share | 0.41 X | 5.01 X |
Total Debt | 4.72 M | 5.32 B |
Debt To Equity | 0.01 % | 48.70 % |
Current Ratio | 4.17 X | 2.16 X |
Book Value Per Share | 3.18 X | 1.93 K |
Cash Flow From Operations | (35.19 M) | 971.22 M |
Short Ratio | 2.38 X | 4.00 X |
Earnings Per Share | (1.83) X | 3.12 X |
Target Price | 8.8 | |
Number Of Employees | 984 | 18.84 K |
Beta | 1.1 | -0.15 |
Market Capitalization | 201.47 M | 19.03 B |
Total Asset | 298.45 M | 29.47 B |
Retained Earnings | (538.53 M) | 9.33 B |
Working Capital | 166.34 M | 1.48 B |
Current Asset | 204.52 M | 9.34 B |
OrganiGram Holdings Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as OrganiGram . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 27428.65 | |||
Daily Balance Of Power | (0.29) | |||
Rate Of Daily Change | 0.99 | |||
Day Median Price | 1.94 | |||
Day Typical Price | 1.94 | |||
Price Action Indicator | (0.03) | |||
Period Momentum Indicator | (0.02) | |||
Relative Strength Index | 46.08 |
About OrganiGram Holdings Buy or Sell Advice
When is the right time to buy or sell OrganiGram Holdings? Buying financial instruments such as OrganiGram Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.2021 | 2022 | 2023 | 2024 (projected) | Total Stockholder Equity | 508.1M | 271.6M | 312.4M | 202.3M | Total Current Liabilities | 55.3M | 22.4M | 25.8M | 18.3M |
Use Investing Ideas to Build Portfolios
In addition to having OrganiGram Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Petroleum and Natural Gas Thematic Idea Now
Petroleum and Natural Gas
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Petroleum and Natural Gas theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Petroleum and Natural Gas Theme or any other thematic opportunities.
View All Next | Launch |
Check out OrganiGram Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in OrganiGram Stock please use our How to Invest in OrganiGram Holdings guide.Note that the OrganiGram Holdings information on this page should be used as a complementary analysis to other OrganiGram Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for OrganiGram Stock analysis
When running OrganiGram Holdings' price analysis, check to measure OrganiGram Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OrganiGram Holdings is operating at the current time. Most of OrganiGram Holdings' value examination focuses on studying past and present price action to predict the probability of OrganiGram Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OrganiGram Holdings' price. Additionally, you may evaluate how the addition of OrganiGram Holdings to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Transaction History View history of all your transactions and understand their impact on performance |
Is OrganiGram Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OrganiGram Holdings. If investors know OrganiGram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OrganiGram Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.83) | Revenue Per Share 1.835 | Quarterly Revenue Growth (0.14) | Return On Assets (0.06) | Return On Equity (0.55) |
The market value of OrganiGram Holdings is measured differently than its book value, which is the value of OrganiGram that is recorded on the company's balance sheet. Investors also form their own opinion of OrganiGram Holdings' value that differs from its market value or its book value, called intrinsic value, which is OrganiGram Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OrganiGram Holdings' market value can be influenced by many factors that don't directly affect OrganiGram Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OrganiGram Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if OrganiGram Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OrganiGram Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.